Fresenius Medical Care AG
FMS
$25.48
$0.190.75%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 25.83% | 27.10% | 8.22% | 49.23% | -7.53% |
Total Depreciation and Amortization | -3.03% | -2.92% | -4.64% | -5.27% | -5.07% |
Total Amortization of Deferred Charges | -7.63% | -7.63% | -7.63% | 8.87% | 3.23% |
Total Other Non-Cash Items | 63.86% | -336.31% | -206.48% | -231.66% | -54.17% |
Change in Net Operating Assets | 375.38% | 3.06% | -21.22% | -28.89% | -40.49% |
Cash from Operations | 36.31% | -7.72% | -9.37% | -8.11% | -12.25% |
Capital Expenditure | -4.31% | -4.16% | -2.08% | -8.99% | -2.47% |
Sale of Property, Plant, and Equipment | -40.86% | -31.93% | -13.56% | -41.94% | -19.02% |
Cash Acquisitions | -303.20% | -530.91% | 81.33% | -103.11% | -90.06% |
Divestitures | -77.29% | 203.45% | 264.91% | 2,124.06% | 1,358.80% |
Other Investing Activities | -529.70% | -530.14% | 33.67% | 79.06% | 112.80% |
Cash from Investing | -14,091.81% | 72.20% | 83.71% | 89.82% | 100.71% |
Total Debt Issued | 2,415.32% | -110.19% | -69.72% | -82.66% | -103.29% |
Total Debt Repaid | -13.30% | 14.54% | -19.07% | -44.19% | 24.77% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -27.60% | -5.06% | -5.06% | -5.06% | -5.06% |
Other Financing Activities | -50.49% | -24.72% | -7.81% | 15.23% | 18.53% |
Cash from Financing | 34.77% | -11.58% | -37.48% | -90.65% | -77.32% |
Foreign Exchange rate Adjustments | -202.91% | 117.49% | 134.95% | 64.63% | 84.22% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 362.32% | -243.58% | -249.86% | -140.13% | -176.74% |